<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01549587</url>
  </required_header>
  <id_info>
    <org_study_id>2011001</org_study_id>
    <nct_id>NCT01549587</nct_id>
  </id_info>
  <brief_title>Oral Hygiene and Maternity Outcomes Multicenter Study (OHMOM)</brief_title>
  <acronym>OHMOM</acronym>
  <official_title>A Randomized Controlled Clinical Trial to Evaluate Late First to Mid-Second Trimester Introduction of Advanced Daily Oral Hygiene on Gingivitis and Maternity Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Procter and Gamble</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Procter and Gamble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will track changes in oral health in pregnant women. Subjects will be assigned to&#xD;
      either regular oral care or advanced oral care and be given oral care products to use until&#xD;
      they deliver. A comparison between the two groups (regular and advanced oral care) will be&#xD;
      made to see if the oral care products impacted oral health and maternity variables.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Actual">April 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in Löe-Silness Gingivitis Index</measure>
    <time_frame>3 months</time_frame>
    <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Löe-Silness Gingivitis Index</measure>
    <time_frame>2 months</time_frame>
    <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change From Baseline in Löe-Silness Gingivitis Index</measure>
    <time_frame>1 month</time_frame>
    <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gestational Age (Weeks)</measure>
    <time_frame>At delivery</time_frame>
    <description>log[42.9-gestational age]</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Neonate Birth Weight (Grams)</measure>
    <time_frame>At delivery</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>Preterm Birth (Gestational Age &lt; 37 Weeks)</measure>
    <time_frame>At delivery</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">746</enrollment>
  <condition>Gingivitis</condition>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>Regular Oral Hygiene</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>toothpaste, toothbrush and dental floss</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Advanced Oral Hygiene plus counseling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.243% sodium fluoride</intervention_name>
    <description>dentifrice: brush thoroughly twice daily</description>
    <arm_group_label>Regular Oral Hygiene</arm_group_label>
    <other_name>Crest® Cavity Protection toothpaste</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>toothbrush</intervention_name>
    <description>brush thoroughly twice daily</description>
    <arm_group_label>Regular Oral Hygiene</arm_group_label>
    <other_name>Oral-B® Indicator toothbrush, regular, soft</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dental floss</intervention_name>
    <description>floss the whole mouth once daily</description>
    <arm_group_label>Regular Oral Hygiene</arm_group_label>
    <other_name>Oral-B® Essentials dental floss</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.454% stannous fluoride</intervention_name>
    <description>dentifrice: twice daily brush thoroughly for 2 minutes</description>
    <arm_group_label>Advanced Oral Hygiene plus counseling</arm_group_label>
    <other_name>Crest® Pro-Health toothpaste</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>toothbrush</intervention_name>
    <description>twice daily brush thoroughly for 2 minutes</description>
    <arm_group_label>Advanced Oral Hygiene plus counseling</arm_group_label>
    <other_name>Oral-B® ProfessionalCare Series 1000 toothbrush, Oral-B® Precision Clean brush head</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.07% Cetylpyridinium chloride</intervention_name>
    <description>mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily</description>
    <arm_group_label>Advanced Oral Hygiene plus counseling</arm_group_label>
    <other_name>Crest® Pro-Health Multi-Protection Mouth Rinse</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dental floss</intervention_name>
    <description>floss the whole mouth once daily</description>
    <arm_group_label>Advanced Oral Hygiene plus counseling</arm_group_label>
    <other_name>Glide® Pro-Health Deep Clean dental floss</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  provide written informed consent prior to participation and be given a signed copy of&#xD;
             the informed consent form;&#xD;
&#xD;
          -  be at least the age of legal consent;&#xD;
&#xD;
          -  be between 8 and 24 weeks of pregnancy;&#xD;
&#xD;
          -  have at least 20 natural teeth;&#xD;
&#xD;
          -  have moderate-to-severe gingivitis during pregnancy, including at least 30 intraoral&#xD;
             sites with evidence of marginal gingival bleeding.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  evidence of multiple gestations;&#xD;
&#xD;
          -  history of HIV infection, AIDS, autoimmune disease, or diabetes other than gestational&#xD;
             diabetes;&#xD;
&#xD;
          -  indication for use of antibiotic pre-medication prior to dental procedures;&#xD;
&#xD;
          -  systemic corticosteroid or immunosuppressive therapy within 1 month of Baseline;&#xD;
&#xD;
          -  severe periodontal disease, rampant untreated dental caries, or other oral conditions&#xD;
             that necessitate immediate dental care;&#xD;
&#xD;
          -  ongoing dental care that in the opinion of the investigator could impact study&#xD;
             participation;&#xD;
&#xD;
          -  a history of allergies or hypersensitivity to mouth rinse products containing CPC;&#xD;
&#xD;
          -  any disease or condition that in the opinion of the investigator could interfere with&#xD;
             the safe completion of the study;&#xD;
&#xD;
          -  randomization to a treatment in study 2011001 during a prior pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marjorie Jeffcoat, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Dentistry University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Reddy, DMD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Dentistry University of Alabama</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Women's Reproductive Health</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294-0024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penn OB/Gyn and Associates</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 28, 2012</study_first_submitted>
  <study_first_submitted_qc>March 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2012</study_first_posted>
  <results_first_submitted>August 31, 2020</results_first_submitted>
  <results_first_submitted_qc>September 22, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 19, 2020</results_first_posted>
  <last_update_submitted>September 22, 2020</last_update_submitted>
  <last_update_submitted_qc>September 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gingivitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Listerine</mesh_term>
    <mesh_term>Cetylpyridinium</mesh_term>
    <mesh_term>Fluorides</mesh_term>
    <mesh_term>Sodium Fluoride</mesh_term>
    <mesh_term>Tin Fluorides</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Regular Oral Hygiene</title>
          <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
        </group>
        <group group_id="P2">
          <title>Advanced Oral Hygiene Plus Counseling</title>
          <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="373"/>
                <participants group_id="P2" count="373"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="334"/>
                <participants group_id="P2" count="336"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="39"/>
                <participants group_id="P2" count="37"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Regular Oral Hygiene</title>
          <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
        </group>
        <group group_id="B2">
          <title>Advanced Oral Hygiene Plus Counseling</title>
          <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="373"/>
            <count group_id="B2" value="373"/>
            <count group_id="B3" value="746"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.6" spread="5.89"/>
                    <measurement group_id="B2" value="27.4" spread="6.01"/>
                    <measurement group_id="B3" value="27.46" spread="5.945"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="373"/>
                    <measurement group_id="B2" value="373"/>
                    <measurement group_id="B3" value="746"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian Oriential</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black</title>
                  <measurement_list>
                    <measurement group_id="B1" value="260"/>
                    <measurement group_id="B2" value="262"/>
                    <measurement group_id="B3" value="522"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Caucasian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="153"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Hispanic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian Indian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Multi-racial</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Löe-Silness Gingivitis Index</title>
        <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
        <time_frame>3 months</time_frame>
        <population>Numbers indicate participants that were evaluable at 3 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Regular Oral Hygiene</title>
            <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
          <group group_id="O2">
            <title>Advanced Oral Hygiene Plus Counseling</title>
            <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Löe-Silness Gingivitis Index</title>
          <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
          <population>Numbers indicate participants that were evaluable at 3 months.</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="267"/>
                <count group_id="O2" value="265"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.141" spread="0.0046"/>
                    <measurement group_id="O2" value="0.154" spread="0.0046"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Löe-Silness Gingivitis Index</title>
        <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
        <time_frame>2 months</time_frame>
        <population>Numbers indicate the participants that were evaluable at 2 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Regular Oral Hygiene</title>
            <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
          <group group_id="O2">
            <title>Advanced Oral Hygiene Plus Counseling</title>
            <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Löe-Silness Gingivitis Index</title>
          <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
          <population>Numbers indicate the participants that were evaluable at 2 months.</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="278"/>
                <count group_id="O2" value="270"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.124" spread="0.0044"/>
                    <measurement group_id="O2" value="0.137" spread="0.0045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in Löe-Silness Gingivitis Index</title>
        <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
        <time_frame>1 month</time_frame>
        <population>Numbers indicate the participants that were evaluable at 1 month</population>
        <group_list>
          <group group_id="O1">
            <title>Regular Oral Hygiene</title>
            <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
          <group group_id="O2">
            <title>Advanced Oral Hygiene Plus Counseling</title>
            <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in Löe-Silness Gingivitis Index</title>
          <description>Score Criteria 0 Normal gingiva.&#xD;
Mild inflammation - slight change in color, slight edema. No bleeding on probing.&#xD;
Moderate inflammation - redness, edema, and glazing. Bleeding on probing.&#xD;
Severe inflammation - marked redness, edema. Ulceration. Tendency to spontaneous bleeding.</description>
          <population>Numbers indicate the participants that were evaluable at 1 month</population>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="275"/>
                <count group_id="O2" value="273"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.112" spread="0.0045"/>
                    <measurement group_id="O2" value="0.125" spread="0.0045"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Gestational Age (Weeks)</title>
        <description>log[42.9-gestational age]</description>
        <time_frame>At delivery</time_frame>
        <population>This data includes the number of subjects who had evaluable data for the obstetric measure (Gestational Age) was 613. Possible reasons for data being declared as non-evaluable includes: being dropped from the study, failing to have enough product for the duration of pregnancy, missing multiple visits, or failing other protocol criteria.</population>
        <group_list>
          <group group_id="O1">
            <title>Regular Oral Hygiene</title>
            <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
          <group group_id="O2">
            <title>Advanced Oral Hygiene Plus Counseling</title>
            <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
        </group_list>
        <measure>
          <title>Gestational Age (Weeks)</title>
          <description>log[42.9-gestational age]</description>
          <population>This data includes the number of subjects who had evaluable data for the obstetric measure (Gestational Age) was 613. Possible reasons for data being declared as non-evaluable includes: being dropped from the study, failing to have enough product for the duration of pregnancy, missing multiple visits, or failing other protocol criteria.</population>
          <units>log weeks</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="302"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3988" spread="0.03394"/>
                    <measurement group_id="O2" value="1.3271" spread="0.03403"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Neonate Birth Weight (Grams)</title>
        <time_frame>At delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Regular Oral Hygiene</title>
            <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
          <group group_id="O2">
            <title>Advanced Oral Hygiene Plus Counseling</title>
            <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
        </group_list>
        <measure>
          <title>Neonate Birth Weight (Grams)</title>
          <units>grams</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="301"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3095.97" spread="46.588"/>
                    <measurement group_id="O2" value="3167.80" spread="45.955"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Preterm Birth (Gestational Age &lt; 37 Weeks)</title>
        <time_frame>At delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Regular Oral Hygiene</title>
            <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
          <group group_id="O2">
            <title>Advanced Oral Hygiene Plus Counseling</title>
            <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
          </group>
        </group_list>
        <measure>
          <title>Preterm Birth (Gestational Age &lt; 37 Weeks)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="311"/>
                <count group_id="O2" value="302"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Participants were enrolled 8-24 weeks into pregnancy until delivery</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Regular Oral Hygiene</title>
          <description>toothpaste, toothbrush and dental floss&#xD;
0.243% sodium fluoride: dentifrice: brush thoroughly twice daily&#xD;
toothbrush: brush thoroughly twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
        </group>
        <group group_id="E2">
          <title>Advanced Oral Hygiene Plus Counseling</title>
          <description>toothpaste, toothbrush, mouth rinse and dental floss plus specialized education&#xD;
0.454% stannous fluoride: dentifrice: twice daily brush thoroughly for 2 minutes&#xD;
toothbrush: twice daily brush thoroughly for 2 minutes&#xD;
0.07% Cetylpyridinium chloride: mouth rinse: rinse with 20 mL of mouth rinse for 30 seconds twice daily&#xD;
dental floss: floss the whole mouth once daily</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="79" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="75" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>CARDIOMEGALY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>FOETAL HEART RATE DECELERATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PULMONARY VALVE STENOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>CHROMOSOMAL DELETION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>FALLOT'S TETRALOGY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>POLYDACTYLY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PULMONARY ARTERY STENOSIS CONGENITAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>RENAL APLASIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>SICKLE CELL ANAEMIA WITH CRISIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>TRANSPOSITION OF THE GREAT VESSELS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>TRISOMY 21</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>VENTRICULAR SEPTAL DEFECT</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL PAIN</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>ABDOMINAL PAIN UPPER</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>DIARRHOEA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>GASTROOESOPHAGEAL REFLUX DISEASE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>RECTAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>CHOLECYSTITIS ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>CHOLELITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>ALLOIMMUNISATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>RHESUS INCOMPATIBILITY</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>APPENDICITIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>CHORIOAMNIONITIS</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>GASTROENTERITIS VIRAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>MENINGITIS VIRAL</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PNEUMONIA</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PYELONEPHRITIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>ABDOMINAL INJURY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>INTENTIONAL OVERDOSE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>BLOOD PRESSURE INCREASED</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>CARDIAC MURMUR</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>FOETAL HEART RATE ABNORMAL</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>DEHYDRATION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>HYPOKALAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>FINGER DEFORMITY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>NOSE DEFORMITY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>CEREBRAL VENTRICLE DILATATION</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>ABORTION MISSED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>ABORTION SPONTANEOUS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>ABORTION THREATENED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>CERVICAL INCOMPETENCE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>FOETAL DISTRESS SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>FOETAL GROWTH RESTRICTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>GESTATIONAL DIABETES</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>GESTATIONAL HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>HAEMORRHAGE IN PREGNANCY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>HELLP SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>IMMINENT ABORTION</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>OLIGOHYDRAMNIOS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PLACENTA PRAEVIA HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PRE-ECLAMPSIA</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PREMATURE DELIVERY</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PREMATURE LABOUR</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PREMATURE RUPTURE OF MEMBRANES</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PREMATURE SEPARATION OF PLACENTA</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>STILLBIRTH</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>UTERINE CONTRACTIONS DURING PREGNANCY</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>KETONURIA</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>NEPHROLITHIASIS</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PYELOCALIECTASIS</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>RENAL FAILURE ACUTE</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>VAGINAL HAEMORRHAGE</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>ACUTE CHEST SYNDROME</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>RESPIRATORY FAILURE</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>ABORTION INDUCED</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>DEEP VEIN THROMBOSIS</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="353" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="329" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>ANAEMIA</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="41" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>NAUSEA</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>VOMITING</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>CHORIOAMNIONITIS</sub_title>
                <counts group_id="E1" subjects_affected="24" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>URINARY TRACT INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="27" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="18" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>VULVOVAGINAL MYCOTIC INFECTION</sub_title>
                <counts group_id="E1" subjects_affected="21" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>STREPTOCOCCUS TEST POSITIVE</sub_title>
                <counts group_id="E1" subjects_affected="88" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="94" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>HEADACHE</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>GESTATIONAL DIABETES</sub_title>
                <counts group_id="E1" subjects_affected="25" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="17" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>GESTATIONAL HYPERTENSION</sub_title>
                <counts group_id="E1" subjects_affected="19" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PRE-ECLAMPSIA</sub_title>
                <counts group_id="E1" subjects_affected="23" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="15" subjects_at_risk="373"/>
              </event>
              <event>
                <sub_title>PREMATURE DELIVERY</sub_title>
                <counts group_id="E1" subjects_affected="40" subjects_at_risk="373"/>
                <counts group_id="E2" subjects_affected="28" subjects_at_risk="373"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>Joint agreement with PIs.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Trial Manager</name_or_title>
      <organization>Procter &amp; Gamble</organization>
      <phone>5136225362</phone>
      <email>combs.cs@pg.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

